Extraskeletal Ewing's Sarcoma with CD7 Positivity and T-cell Receptor/Immunoglobulin Rearrangement Masquerading as T-lymphoblastic Lymphoma

Fetal Pediatr Pathol. 2022 Jun;41(3):499-504. doi: 10.1080/15513815.2020.1845885. Epub 2020 Nov 19.

Abstract

Background: Extraskeletal Ewing's Sarcoma (EES) may harbor more than one tumor-specific genetic abnormality, leading to diagnostic difficulties. Case report: We report a nine-year-old boy with recurrent mass of his right thigh. Tumor cells were round, with scant cytoplasm, finely dispersed chromatin, and inapparent, small nucleoli. The initial misdiagnosis was T-lymphoblastic lymphoma due to CD7 and TCR/Ig monoclonal rearrangement. As it expressed NKX2.2 and harbored an EWSR1-FLI1 fusion transcript, the diagnosis was changed to EES. The child underwent EES therapy with good initial response, but had a subcutaneous relapse at 22 months. Conclusion: In addition to typical genetic alterations, Ewing sarcoma can also express CD7 and TCR/Ig rearrangement, which are not limited to lymphoma.

Keywords: EWSR1 rearrangement; Extraskeletal Ewing's sarcoma; TCR/Ig rearrangement; lymphoblastic lymphoma.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Humans
  • Immunoglobulins
  • Male
  • Neoplasm Recurrence, Local
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma*
  • Receptors, Antigen, T-Cell
  • Sarcoma, Ewing* / diagnosis
  • Sarcoma, Ewing* / genetics
  • Sarcoma, Ewing* / pathology

Substances

  • Immunoglobulins
  • Receptors, Antigen, T-Cell